相关实验视频

Updated: May 5, 2026

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique
08:38

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique

Published on: July 15, 2021

3.8K

在ACDF后使用GLP-1受体激素和术后结果:倾向匹配的队列研究

Kevin Y Heo1, Stephen R Barchick1, Aubrie M Sowa1

  • 1Department of Orthopaedic Surgery, Emory University School of Medicine, 21 Ortho Ln, Atlanta, Georgia, 30329.

The spine journal : official journal of the North American Spine Society
|January 2, 2026
PubMed
概括

No abstract available in PubMed .

关键词:
前宫椎切除和融合一个GLP-1受体激动剂葡萄糖类-1受体激动剂肥胖问题手术后的医学并发症手术后的并发症第2类糖尿病

更多相关视频

Clinical Application of Microscope-Assisted Minimally Invasive Anterior Lumbar Interbody Fusion04:42

Clinical Application of Microscope-Assisted Minimally Invasive Anterior Lumbar Interbody Fusion

Published on: June 16, 2023

925
Multilevel Oblique Lumbar Interbody Fusion in Degenerative Lumbar Disc Disease with Instability11:30

Multilevel Oblique Lumbar Interbody Fusion in Degenerative Lumbar Disc Disease with Instability

Published on: July 25, 2025

1.0K

相关概念视频

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K